The European Patent Office (EPO) has granted patent EP3110948B1, which pertains to variants of chymosin designed to enhance milk-clotting properties. This patent, effective March 18, 2026, covers specific genetic modifications and applications of these enzymes in the dairy industry. The designated states include numerous European countries, indicating a broad territorial scope for the patent.

While this is a patent grant and not a regulatory rule imposing direct compliance obligations on companies, it signifies a new intellectual property right in the field of biotechnology and food production. Companies operating in the dairy enzyme sector, particularly those developing or utilizing chymosin-based products, should be aware of this granted patent to ensure they do not infringe on the intellectual property rights of the patent holder. No immediate compliance actions are required, but it may influence future product development and licensing strategies.